论文部分内容阅读
BACKGROUND AND OBJECTIVE:To evaluate the results of phacoemulsification and posterior chamber intraocular lens(IOL) implantation in patients with uveitis.PATIENTS AND METHODS:Review of records of 37 eyes of 31 patients with uveitis(14men and 17women;mean age,49.8 years;age range,26 to 71 years) who underwent phacoemulsification with IOL implantation.The data recorded were age,gender,IOL type,treatment modalities,final visual outcome,and complications.RESULTS:Panuveitis,anterior uveitis,posterior uveitis,and intermediate uveitis were detected in 16(51.6%) ,9(29.0%) ,5(16.1%) ,and 1(3.3%) of the patients,respectively.At 6 months postoperatively,32(86.5%) eyes had achieved a best corrected visual acuity of 20/40 or better,and 22(59.5%) eyes had a visual acuity of 20/20.Five(13.5%) eyes showed limited improvement in postoperative visual acuity due to posterior segment problems.Postoperative recurrence of inflammation occurred in 12 eyes(32.4%) of 10 patients and was treated and controlled with medical therapy.CONCLUSION:When inflammation in uveitic eyes is under complete control,phacoemulsification and implantation of a foldable acrylic IOL in the posterior chamber is safe,effective,and tolerated well.To minimize vision-limiting complications,these patients must be observed closely after surgery,and must be treated aggressively if the inflammation recurs.
BACKGROUND AND OBJECTIVE: To evaluate the results of phacoemulsification and posterior chamber intraocular lens (IOL) implantation in patients with uveitis. PATIENTS AND METHODS: Review of records of 37 eyes of 31 patients with uveitis (14men and 17 wrist; mean age, 49.8 years; age range, 26 to 71 years) who underwent phacoemulsification with IOL implantation. data recorded were age, gender, IOL type, treatment modalities, final visual outcome, and complications. RESULTS: Panuveitis, anterior uveitis, posterior uveitis, and intermediate uveitis were detected in 16 (51.6%) 9 (29.0%) 5 (16.1%) and 1 (3.3%) of the patients, respectively. At 6 months postoperatively 32 (86.5%) eyes had achieved a best corrected visual acuity of 20/40 or better, and 22 (59.5%) eyes had a visual acuity of 20 / 20.Five (13.5%) eyes showed limited improvement in postoperative visual acuity due to posterior segment problems. (32.4%) of 10 patients and was treated and controlled with medical therapy. CONCLUSION: When inflammation in uveitic eyes is under complete control, phacoemulsification and implantation of a foldable acrylic IOL in the posterior chamber is safe, effective, and tolerated well. minimized vision-limiting complications, these patients must be seen closely after surgery, and must be treated aggressively if the inflammation recurs.